Home/Filings/4/0001127602-23-014615
4//SEC Filing

Lynch Karen S 4

Accession 0001127602-23-014615

CIK 0000064803other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 8:27 AM ET

Size

14.7 KB

Accession

0001127602-23-014615

Insider Transaction Report

Form 4
Period: 2023-05-03
Rohan Karen
EVP & Pres, Aetna Bus Unit
Transactions
  • Purchase

    Common Stock (By Trust)

    2023-05-03$69.75/sh+14,000$976,567431,392 total
Holdings
  • Stock Appreciation Rights

    Exercise: $37.91From: 2019-02-19Exp: 2026-02-18Common Stock (93,989 underlying)
    93,989
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (242,408 underlying)
    242,408
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (224,604 underlying)
    224,604
  • Stock Appreciation Rights

    Exercise: $45.91From: 2019-02-17Exp: 2027-02-16Common Stock (192,741 underlying)
    192,741
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (211,196 underlying)
    211,196
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (171,517 underlying)
    171,517
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (244,952 underlying)
    244,952
Footnotes (8)
  • [F1]Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Plan on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vest in two substantially equal annual installments beginning on February 17, 2019.
  • [F2]Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F4]The number of shares subject to the option were calculated using a 30-day average price.
  • [F5]Option became exercisable in four equal installments, commencing 4/1/2021.
  • [F6]Option became exercisable in four equal installments, commencing 4/1/2022.
  • [F7]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F8]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001333760

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 8:27 AM ET
Size
14.7 KB